Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06003127 · ClinicalTrials.gov registry record · NA

REcovery From DEXmedetomidine-induced Unconsciousness

A NA study of Healthy and Anesthesia, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06003127 is a NA study of Healthy and Anesthesia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 12 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06003127, a NA study of Healthy and Anesthesia, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This pilot study in healthy volunteers aims to determine if biological sex has an impact on recovery from dexmedetomidine-induced unconsciousness, and if transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) can be used to measure brain complexity during dexmedetomidine sedation without arousing study participants.

Interventions

  • DEVICE Transcranial Magnetic Stimulation-Electroencephalography

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-11-15
Est. Completion 2026-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06003127

The ClinicalTrials.gov registry entry for NCT06003127 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation-Electroencephalography is the first listed.

NCT06003127 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06003127 about?

NCT06003127 is a clinical study titled "REcovery From DEXmedetomidine-induced Unconsciousness". This pilot study in healthy volunteers aims to determine if biological sex has an impact on recovery from dexmedetomidine-induced unconsciousness, and if transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) can be used to measure brain complexity during dexmedetomidine se...

What is the current status of trial NCT06003127?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-11-15. Estimated completion is 2026-12.

What conditions does trial NCT06003127 study?

This clinical trial studies the following conditions: Healthy, Anesthesia, Consciousness, Level Altered.

What interventions are being tested in trial NCT06003127?

The interventions under investigation include: Transcranial Magnetic Stimulation-Electroencephalography (DEVICE).

Who is sponsoring clinical trial NCT06003127?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06003127 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.